18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging … J Calais, F Ceci, M Eiber, TA Hope, MS Hofman, C Rischpler, ... The Lancet Oncology 20 (9), 1286-1294, 2019 | 388 | 2019 |
Prostate cancer: PET with 18F-FDG, 18F-or 11C-acetate, and 18F-or 11C-choline H Jadvar Journal of Nuclear Medicine 52 (1), 81-89, 2011 | 359 | 2011 |
The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0 EB Silberstein, A Alavi, HR Balon, SEM Clarke, C Divgi, MJ Gelfand, ... Journal of Nuclear Medicine 53 (10), 1633-1651, 2012 | 341 | 2012 |
Expandable esophageal catheter WT Metzger, H Jadvar US Patent 5,117,828, 1992 | 321 | 1992 |
18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization H Jadvar, A Alavi, SS Gambhir Journal of Nuclear Medicine 50 (11), 1820-1827, 2009 | 274 | 2009 |
Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings R Tatlidil, H Jadvar, JR Bading, PS Conti Radiology 224 (3), 783-787, 2002 | 258 | 2002 |
Competitive advantage of PET/MRI H Jadvar, PM Colletti European journal of radiology 83 (1), 84-94, 2014 | 221 | 2014 |
Still the great mimicker: abdominal tuberculosis. H Jadvar, RE Mindelzun, EW Olcott, DB Levitt AJR. American journal of roentgenology 168 (6), 1455-1460, 1997 | 207 | 1997 |
Future cancer research priorities in the USA: a Lancet Oncology Commission EM Jaffee, C Van Dang, DB Agus, BM Alexander, KC Anderson, ... The Lancet Oncology 18 (11), e653-e706, 2017 | 195 | 2017 |
A systematic review on diagnostic accuracy of CT-based detection of significant coronary artery disease BJ d’Othée, U Siebert, R Cury, H Jadvar, EJ Dunn, U Hoffmann European Journal of Radiology 65 (3), 449-461, 2008 | 192 | 2008 |
PSMA theranostics: current status and future directions K Rahbar, A Afshar-Oromieh, H Jadvar, H Ahmadzadehfar Molecular imaging 17, 1536012118776068, 2018 | 190 | 2018 |
Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations H Jadvar European journal of nuclear medicine and molecular imaging 40, 5-10, 2013 | 174 | 2013 |
Is there use for FDG-PET in prostate cancer? H Jadvar Seminars in nuclear medicine 46 (6), 502-506, 2016 | 171 | 2016 |
Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer H Jadvar, B Desai, L Ji, PS Conti, TB Dorff, SG Groshen, ME Gross, ... Clinical nuclear medicine 37 (7), 637-643, 2012 | 154 | 2012 |
Optimum imaging strategies for advanced prostate cancer: ASCO guideline EJ Trabulsi, RB Rumble, H Jadvar, T Hope, M Pomper, B Turkbey, ... Journal of Clinical Oncology 38 (17), 1963-1996, 2020 | 152 | 2020 |
Method and apparatus for detection of posterior ischemia H Jadvar, RC Arzbaecher US Patent 5,010,888, 1991 | 139 | 1991 |
PET and PET/CT in pediatric oncology H Jadvar, LP Connolly, FH Fahey, BL Shulkin Seminars in nuclear medicine 37 (5), 316-331, 2007 | 138 | 2007 |
Baseline 18F-FDG PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer H Jadvar, B Desai, L Ji, PS Conti, TB Dorff, SG Groshen, JK Pinski, ... Journal of Nuclear Medicine 54 (8), 1195-1201, 2013 | 136 | 2013 |
Molecular imaging of prostate cancer: PET radiotracers H Jadvar American Journal of Roentgenology 199 (2), 278-291, 2012 | 136 | 2012 |
Variable stiffness esophageal catheter WT Metzger, H Jadvar US Patent 4,930,521, 1990 | 132 | 1990 |